| __timestamp | Soleno Therapeutics, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 13774000 |
| Thursday, January 1, 2015 | 7878291 | 22479000 |
| Friday, January 1, 2016 | 8366794 | 27388000 |
| Sunday, January 1, 2017 | 6610381 | 35610000 |
| Monday, January 1, 2018 | 6556000 | 49007000 |
| Tuesday, January 1, 2019 | 6930000 | 61139000 |
| Wednesday, January 1, 2020 | 8758000 | 68836000 |
| Friday, January 1, 2021 | 10806000 | 97592000 |
| Saturday, January 1, 2022 | 9844000 | 106903000 |
| Sunday, January 1, 2023 | 13481000 | 120998000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, operational efficiency is paramount. Over the past decade, Vericel Corporation and Soleno Therapeutics, Inc. have showcased contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Vericel's SG&A expenses surged by approximately 780%, reflecting its aggressive expansion and market penetration strategies. In contrast, Soleno's expenses grew by about 360%, indicating a more conservative approach.
This analysis underscores the diverse strategies employed by biotech firms in managing operational costs, offering valuable insights for investors and industry stakeholders.
Cost Management Insights: SG&A Expenses for argenx SE and Soleno Therapeutics, Inc.
BeiGene, Ltd. vs Vericel Corporation: SG&A Expense Trends
Neurocrine Biosciences, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Vericel Corporation
Cost Management Insights: SG&A Expenses for MorphoSys AG and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Vericel Corporation vs Merus N.V. Trends and Insights
Cost Management Insights: SG&A Expenses for Vericel Corporation and Supernus Pharmaceuticals, Inc.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Soleno Therapeutics, Inc. vs Dynavax Technologies Corporation: SG&A Expense Trends
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights